Market Overview:
The global biotherapeutics market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for biotherapeutics products, and technological advancements in the field of biotherapeutics. The global biotherapeutics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into transfection and single cell cloning. The transfection segment is further sub-segmented into viral vectors and non-viral vectors. The single cell cloning segment is further sub-segmented into somatic cells and stem cells. On the basis of application, the market is divided into clinical treatment, scientific research, and others (including diagnostics). Clinical treatment dominates this sector owing to rising incidences chronic diseases such as cancer & diabetes mellitus which require novel therapeutics for their cure or management are fuelling demand for novel therapies including those delivered via recombinant proteins/peptides or monoclonal antibodies (mAbs).
Product Definition:
The term "biotherapeutics" refers to therapies that use living organisms, or products derived from them, to treat disease. Biotherapeutics can be divided into two main categories: biologics and vaccines. Biologics are therapeutic proteins produced by microorganisms, plants, or animals. Vaccines are preparations containing killed or weakened forms of viruses, bacteria, or other pathogens that are used to prevent infection.
Transfection:
Transfection is the process of incorporating a gene or genes into another organism's DNA. It can be done by two methods: non-electrochemical and electrochemical. The most common way to do transfection is by the calcium phosphate method which involves using an insoluble form of calcium phosphate, such as what happens in milk, to carry the cargillium plasmid DNA into plant cells.
Single Cell Cloning:
Single cell cloning is a process of isolating and reproducing an individual cell. This has been done for many years in the laboratories, but with technological advancements it can be easily done in the comfort of one's home setting. The main purpose of this procedure is to create genetically modified cells that possess new and useful properties for therapeutic purposes. These procedures have created huge opportunities in fields such as regenerative medicine, cancer research, stem cell therapy etc.
Application Insights:
The clinical treatment segment dominated the global biOthersapeutics market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to increasing prevalence of chronic diseases, growing geriatric population, and rising healthcare expenditure globally. According to WHO, in 2016 approximately 1.7 billion people aged 60 years or above were present in the world while around 1.6 billion people aged between 15-59 years were present in the world which represented a rise of more than 20% from 1990 levels.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of biotechnology companies, which are engaged in developing and commercializing biosimilars. The U.S., as well as Canada, is one of the most lucrative markets for biotherapeutics due to factors such as favorable government policies and an increase in R&D investments by various companies over the past few years.
Asia Pacific is expected to witness significant growth during the forecast period owing to increasing healthcare spending by countries like China and India along with rising awareness about advanced therapies among patients & physicians (patients). Moreover, growing efforts towards development of novel drugs targeting unmet medical needs are expected drive regional market growth over next eight years.
The key players operating in this space include Novartis AG; Pfizer Inc.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The BiOthersapeutics market is expected to benefit from this trend as it offers novel therapies and treatments for chronic diseases.
- Growing demand for personalized medicines: A major trend in the BiOthersapeutics market is the growing demand for personalized medicines. This is driven by the need to treat individual patients with specific therapies that are tailored to their needs. The BiOthersapeutics market is expected to benefit from this trend as it offers a wide range of personalized therapies and treatments.
- Advances in biotechnology: The field of biotechnology has been making rapid advances in recent years, thanks to breakthroughs in areas such as gene editing and stem cell therapy. This has led to a number of new products being launched in the BiOthersapeutics market, which are offering better treatment options for patients worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
BiOthersapeutics Market Research Report
By Type
Transfection, Single Cell Cloning
By Application
Clinical Treatment, Scientific Research, Others
By Companies
Beckman Coulter, Boehringer Ingelheim Pharma, CMC Biologics, Lonza Group, Partec, ProBioGen, SAFC, Selexis, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global BiOthersapeutics Market Report Segments:
The global BiOthersapeutics market is segmented on the basis of:
Types
Transfection, Single Cell Cloning
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Treatment, Scientific Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Beckman Coulter
- Boehringer Ingelheim Pharma
- CMC Biologics
- Lonza Group
- Partec
- ProBioGen
- SAFC
- Selexis
- Thermo Fisher Scientific
Highlights of The BiOthersapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transfection
- Single Cell Cloning
- By Application:
- Clinical Treatment
- Scientific Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the BiOthersapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
BiOthersapeutics is a biotechnology company that develops and commercializes novel therapeutics for the treatment of diseases. The company's products include small molecule drugs and antibody-drug conjugates (ADCs).
Some of the major companies in the biothersapeutics market are Beckman Coulter, Boehringer Ingelheim Pharma, CMC Biologics, Lonza Group, Partec, ProBioGen, SAFC, Selexis, Thermo Fisher Scientific.
The biothersapeutics market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 BiOthersapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 BiOthersapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 BiOthersapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the BiOthersapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global BiOthersapeutics Market Size & Forecast, 2020-2028
4.5.1 BiOthersapeutics Market Size and Y-o-Y Growth
4.5.2 BiOthersapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Transfection
5.2.2 Single Cell Cloning
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinical Treatment
6.2.2 Scientific Research
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global BiOthersapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 BiOthersapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Transfection
9.6.2 Single Cell Cloning
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinical Treatment
9.10.2 Scientific Research
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Transfection
10.6.2 Single Cell Cloning
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinical Treatment
10.10.2 Scientific Research
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Transfection
11.6.2 Single Cell Cloning
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinical Treatment
11.10.2 Scientific Research
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Transfection
12.6.2 Single Cell Cloning
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinical Treatment
12.10.2 Scientific Research
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Transfection
13.6.2 Single Cell Cloning
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinical Treatment
13.10.2 Scientific Research
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 BiOthersapeutics Market: Competitive Dashboard
14.2 Global BiOthersapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Beckman Coulter
14.3.2 Boehringer Ingelheim Pharma
14.3.3 CMC Biologics
14.3.4 Lonza Group
14.3.5 Partec
14.3.6 ProBioGen
14.3.7 SAFC
14.3.8 Selexis
14.3.9 Thermo Fisher Scientific
